Epic Corp. (OTCPINK: EPOR)
52 week range: .03 to .55/share
Current share structure based on last annual report at Otcmarkets.com
Market Value1 $1.2M a/o Dec 10, 2012
Shares Outstanding 26M a/o Sep 30, 2012
Float 4.6M a/o Jul 18, 2012
Authorized Shares 150M a/o Dec 31, 2011
We estimate a public float of around 6.7M shares based on insider holdings in the last public filing
Business Description
EPIC is dedicated to making an impact on peoples lives. We strive to provide better health care through the development and commercialization of new technology. We realize, we cannot prosper in isolation. We and our strategic partners are using various technologies to develop economical devices to reduce trauma, aid in diagnosing diseases, and provide comfort. We are committed to grow our business by focusing on research and development, production, marketing, and sales of Health care products and services.
We achieve success through research and development conducted in conjunction with our affiliates and strategic partners. Our driving force is innovation in our products and financial matters, both measured in human and financial terms. In seeking the fulfillment of our mission, we are guided by values that establish who we are.
We were founded in October 1997, in the State of Colorado, and in September 1999 we became a full reporting company under the Securities Exchange Act of 1934 and started trading on the Bulletin Board. In December 2001 we voluntarily withdrew our registration under the Exchange Act, and have since traded on the OTC Markets. We survived the days of the "new economy" when our price was as high as $7.00 per share in March 2000 and descended to $0.01 more than a year later.
We commenced business as fab-less semi-conduct company, then evolved in to an information appliance company, a financial services holding company specializing in the development of subsidiary and affiliated companies. Then in 2006 we commenced focusing on the health care industry with the formation of RX Health care Systems, Ltd.
Our plan is to enter into agreements with companies developing technology for health care products. The essence of these agreements is to aid the companies with product commercialization, product procurement, marketing and distribution. Then once a product receives regulatory approval, if needed, and can be sold, we become the financial manager of a joint venture, directly or indirectly, with the research and development company.
The company for the next 12 months, will commence selling the AcuFAB and AcuPAD
Industry comparables:
Span-America Medical Systems Inc. (Nasdaq: SPAN)
52 week range: $13.35 to $19.93/share
Market cap: 54M
EBITDA: 8.71M
Invacare Corp (NYSE: IVC)
52 week range: $12.87 to $19.85/share
Market Cap: 462M
EBITDA: 131.22M
$18 billion per year in hospitalization cost
In 2011, a market study was performed to estimate the treatment costs and the costs of hospitals stays for patients who developed ulcers during hospitalization. These costs were estimated to be as much as $18 billion a year. In elderly populations and in those who are institutionalized, pressure ulcers are one of the most costly diseases to treat. These ulcers add an estimated burden of over $3 billion of expenditures and an additional 4.3 million Medicare hospital days to the United States health care system. The cost of treatment is $2000-$40,000 per pressure ulcer, depending on the stage of development.
For reconstructive surgery, costs are estimated at $25,000 per patient. These costs alone, without the cost of human suffering, demonstrate the importance of preventing pressure ulcers and of cost effective treatment practices. A 2011 cost-effective analysis study by Pham et al determined that both clinical and economic evidence maintains that pressure redistribution mattresses should be used to prevent pressure ulcers in long-term care patients. In addition, the study found that perineal foam cleansers and dry skin emollients are also economical ways to stop pressure ulcers from developing. Pham et al also concluded in a separate study that pressure redistribution foam mattresses should also be used to help improve elderly patients' health. http://emedicine.medscape.com/article/319284-overview
OxBridge Research
helping tomorrows fortune 500 companies TODAY!
Full Research Report: https://dl.dropbox.com/u/71480488/EPIC%20Mark...igence.pdf
Conclusion:
Epic Corporation has a proprietary and patent protected manufacturing process for a fabric solution which offers great advantages to the surface tissue in contact with it. In a world where we have major problems with sedentary lifestyles, poor eating habits, and health care issues, these solutions may be the answer for patients everywhere. What is most intriguing is that these products have some technological barriers to entry yet do not have to go through the rigorous FDA approval process. With some very reasonable hurdles, the company can get reimbursement for its products as the economic problem is very real and very large. This company is a very good way to play a global trend when the sentiment around such opportunities is at its lowest. The most compelling thing about this opportunity is its very low valuation, limited operational burn rate and its proprietary processes. Further, the mar ket overall is growing rapidly, and the overall demographic trend is fully intact. Finally, this company is a very good place to be if in fact the trend of pressure alleviation catches on in a very real way and transcends the existing products the company is currently involved with. There may be a large segment for custom business in several areas which have up until now not been looked at. This is a call option for the company as there are many areas such as gloves, footwear, hospital gowns, etc., where these products may very well be applicable and this is where It really gets interesting.
Happy Holiday's From The Team at FPP
As always bringing you the hottest uncompensated micro-cap stocks ahead of the crowd!
Recent Winners: ATRN 3600% , AUCI 200%, AXLX 300%, CMGO 900%, JNSH 250%, EGOC 300%, AMBS 750% VIP Twitter only Alert
Join our early alert / pre-promotion VIP membership for only $29.95/month for a limited time.
VIP's get exclusive access to our protected VIP twitter account and receive early alerts on our feature profiles as well as watch alerts on Nasdaq, NYSE, OTC, and Pinksheets stocks.
http://www.firstpennypicks.com/vip-membership/
Contact us: Info@FirstPennyPicks.com
FIRST PENNY PICKS DISCLAIMER
First Penny Picks Disclaimer is to be read and fully understood before using FirstPennyPicks.COM, or Joining our First Penny Picks Group or Newsletter.
Please note that FirstPennyPicks.COM employees are not registered as an Investment Adviser in any jurisdiction whatsoever.
We do not accept compensation for any of the companies profiled in our newsletter. We do however, from time to time buy shares in the companies profiled. If Firstpennypicks.com employees ,owners, or affiliates own shares in a profiled company the amount of shares will be listed at the bottom of each email. Firstpennypicks.com reserves the right to buy or sell shares in the profiled companies any time before during or after the advertisement is sent to our members. FPP's employees own a combined total of 180K shares of EPOR.
READ OUR FULL DISCLAIMER AT http://Firstpennypicks.com
